Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Glioblastoma 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Somatostatinoma 1Pheochromocytoma 1Ovarian Neoplasms 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Metastatic Non-hematologic Malignancies 1Melanoma 1Kidney Neoplasms 1Insulinoma 1Glucagonoma 1Gliosarcoma 1Glioma 1Gastrinoma 1Fallopian Tube Neoplasms 1Ependymoma 1Endometrial Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Merkel Cell 1Carcinoma, Medullary 1Carcinoma, Islet Cell 1Carcinoma 1Breast Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

vandetanib 2cabozantinib 2Trastuzumab 2Magnetic Resonance Spectroscopy 2Everolimus 2veliparib 1vatalanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1temsirolimus 1sargramostim 1pentetreotide 1mercaptoundecahydrododecaborate 1gallium Ga 68 dotatate 1fludarabine 1cixutumumab 1Vinorelbine 1Temozolomide 1Specimen Handling 1Sirolimus 1Semaxinib 1Salts 1Ranitidine 1Paclitaxel 1Omeprazole 1Octreotide 1Nivolumab 1Interleukin-12 Subunit p35 1Interleukin-12 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Carcinoma, Medullary × vatalanib × Clear all
NCT00655655 2024-08-21

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Completed
96 enrolled
DermatologicEndocrineGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glucagonoma, Insulinoma, Melanoma, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡